A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases
Clinical trial NCT01834651 · COMPLETED
Trial details
- NCT number
- NCT01834651
- Sponsor
- Edwin Posadas, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-30
- Primary completion
- 2016-07-18
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.